$Mersana Therapeutics (MRSN.US)$
What is Mersana Therapeutics' (MRSN) main focus in cancer treatment?
Mersana Therapeutics focuses on discovering and developing antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need.
Exclusive: Mersana Therapeutics CEO to Reveal ADC Pipeline Updates at Guggenheim Conference

$Mersana Therapeutics (MRSN.US)$ this is the way

$Mersana Therapeutics (MRSN.US)$
Citi recently initiated coverage on Mersana Therapeutics with a Buy rating, spotlighting the potential of the company's XMT-1660 project. The firm's coverage transfer to analyst Yigal Nochomovitz comes with optimistic expectations for the XMT-1660 data. This upcoming data is seen as a significant catalyst that could revitalize interest in the company's shares.
On the clinical front, Mersana's XMT-1660 h...

$Mullen Automotive (MULN.US)$ racing with $Mersana Therapeutics (MRSN.US)$

$Mersana Therapeutics (MRSN.US)$ I think 0.81 is in the safe zone

$Mersana Therapeutics (MRSN.US)$ .9 lfg